BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38788065)

  • 21. Imputed gene expression risk scores: a functionally informed component of polygenic risk.
    Pain O; Glanville KP; Hagenaars S; Selzam S; Fürtjes A; Coleman JRI; Rimfeld K; Breen G; Folkersen L; Lewis CM
    Hum Mol Genet; 2021 May; 30(8):727-738. PubMed ID: 33611520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.
    Gibson J; Russ TC; Adams MJ; Clarke TK; Howard DM; Hall LS; Fernandez-Pujals AM; Wigmore EM; Hayward C; Davies G; Murray AD; Smith BH; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2017 Apr; 7(4):e1094. PubMed ID: 28418403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
    Harrison JR; Mistry S; Muskett N; Escott-Price V
    J Alzheimers Dis; 2020; 74(4):1271-1283. PubMed ID: 32250305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving predictive models for Alzheimer's disease using GWAS data by incorporating misclassified samples modeling.
    Romero-Rosales BL; Tamez-Pena JG; Nicolini H; Moreno-Treviño MG; Trevino V
    PLoS One; 2020; 15(4):e0232103. PubMed ID: 32324812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    Handy A; Lord J; Green R; Xu J; Aarsland D; Velayudhan L; Hye A; Dobson R; Proitsi P; ;
    J Alzheimers Dis; 2021; 83(4):1825-1839. PubMed ID: 34459398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
    Kikuchi M; Miyashita A; Hara N; Kasuga K; Saito Y; Murayama S; Kakita A; Akatsu H; Ozaki K; Niida S; Kuwano R; Iwatsubo T; Nakaya A; Ikeuchi T; ;
    Alzheimers Res Ther; 2024 Feb; 16(1):45. PubMed ID: 38414085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
    Privé F; Aschard H; Blum MGB
    Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
    Clark K; Leung YY; Lee WP; Voight B; Wang LS
    J Alzheimers Dis; 2022; 89(1):1-12. PubMed ID: 35848019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.
    Hrytsenko Y; Shea B; Elgart M; Kurniansyah N; Lyons G; Morrison AC; Carson AP; Haring B; Mitchell BD; Psaty BM; Jaeger BC; Gu CC; Kooperberg C; Levy D; Lloyd-Jones D; Choi E; Brody JA; Smith JA; Rotter JI; Moll M; Fornage M; Simon N; Castaldi P; Casanova R; Chung RH; Kaplan R; Loos RJF; Kardia SLR; Rich SS; Redline S; Kelly T; O'Connor T; Zhao W; Kim W; Guo X; Ida Chen YD; ; Sofer T
    Sci Rep; 2024 May; 14(1):12436. PubMed ID: 38816422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects.
    Cáceres A; Vargas JE; González JR
    Alzheimers Dement; 2017 Apr; 13(4):493-497. PubMed ID: 27337227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Risks of Dry Eye Disease Development Using a Genome-Wide Polygenic Risk Score Model.
    Hsu CC; Chuang HK; Hsiao YJ; Chiang PH; Chen SW; Luo WT; Yang YP; Tsai PH; Chen SJ; Hsieh AR; Chiou SH
    Transl Vis Sci Technol; 2024 May; 13(5):13. PubMed ID: 38767906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The construction of cross-population polygenic risk scores using transfer learning.
    Zhao Z; Fritsche LG; Smith JA; Mukherjee B; Lee S
    Am J Hum Genet; 2022 Nov; 109(11):1998-2008. PubMed ID: 36240765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitively healthy centenarians are genetically protected against Alzheimer's disease.
    Tesi N; van der Lee S; Hulsman M; van Schoor NM; Huisman M; Pijnenburg Y; van der Flier WM; Reinders M; Holstege H
    Alzheimers Dement; 2024 Jun; 20(6):3864-3875. PubMed ID: 38634500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring heritable contributions to Alzheimer's disease: polygenic risk score analysis with twins.
    Karlsson IK; Escott-Price V; Gatz M; Hardy J; Pedersen NL; Shoai M; Reynolds CA
    Brain Commun; 2022; 4(1):fcab308. PubMed ID: 35169705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probability of Alzheimer's disease based on common and rare genetic variants.
    Escott-Price V; Schmidt KM
    Alzheimers Res Ther; 2021 Aug; 13(1):140. PubMed ID: 34404470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.